Karine Tawagi, MD

Karine Tawagi, MD, is a hematologist/oncologist and assistant professor of clinical medicine at the University of Illinois

Articles

Urothelial ESMO 2025 Updates

November 11th 2025

OncLive partnered with Two Onc Docs to review updates from the 2025 ESMO Congress on bladder cancer management that may change guidelines.

Metastatic Breast Cancer 2025 UPDATE

October 20th 2025

In this episode, Two Onc Docs review the current management of metastatic breast cancer, emphasizing treatment strategies across molecular subtypes.

Recent FDA Approvals and Ongoing Research Expand Treatment Options for Soft Tissue Sarcoma: With Samantha A. Armstrong, MD; and Karine Tawagi, MD

September 8th 2025

Drs Armstrong and Tawagi discuss key aspects of soft tissue sarcoma management.

Endometrial (Uterine) Cancer 2025 UPDATE

August 11th 2025

Drs Armstrong and Tawagi reviewed diagnostic, staging, and treatment principles in uterine cancer and recent advances in immunotherapy.

ASCO 2025 Plenary — MATTERHORN

July 7th 2025

Drs Armstrong and Tawagi discussed key data from the phase 3 MATTERHORN trial, which were presented at the 2025 ASCO Annual Meeting.

ASCO 2025 Plenary: SERENA-6

June 24th 2025

Drs Armstrong and Tawagi discuss key efficacy, safety, and patient-reported outcomes from the phase 3 SERENA-6 study.

Board Review Resources 2024

September 30th 2024

Drs Armstrong and Tawagi discuss the board review plans they followed in the months leading up to their hematology and oncology board exams.

Heme & Onc Fellow Board Review Tips 2024

September 9th 2024

Drs Armstrong and Tawagi discuss high-yield oncology and hematology topics to focus on when studying for the 2024 oncology board exams.

ASCO 2024 Plenary: NADINA Trial Neoadjuvant Ipi/Nivo vs Adjuvant Nivo for Resectable Stage III Melanoma

August 12th 2024

Drs Armstrong and Tawagi discuss the NADINA trial of neoadjuvant nivolumab/ipilimumab vs adjuvant nivolumab in resectable, macroscopic, stage III melanoma.

ASCO 2024 Plenary: ADRIATIC Trial in Limited-Stage Small Cell Lung Cancer

July 8th 2024

OncLive On Air partners with Two Onc Docs to bring insights on the ADRIATIC trial, data from which were presented at the 2024 ASCO Annual Meeting.

ASCO 2024 Plenary: LAURA Trial in Unresectable Stage III EGFRm NSCLC

June 10th 2024

OncLive On Air partners with Two Onc Docs to bring insights on primary data from the LAURA trial, which were presented at the 2024 ASCO Annual Meeting.